AquaBounty in talks for royalty deal as FDA approval

(07/10/18)

 clears pathway to growth

AquaBounty Technologies, having obtained key Food & Drug Administration (FDA) approval for its genetically modified salmon, is speaking to potential partners to fast-track the growing of the fish around the world.

The company has held talks with Chinese aquaculture companies among others, AquaBounty CEO Ron Stotish told Undercurrent News.

The model would involve creating a “network of partnerships” in which AquaBounty supplies both genetics and................................................


Click here to read the rest of this article:
https://www.undercurrentnews.com/